BeiGene Ltd (HK:6160) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BeiGene, Ltd., a biotechnology company, has released an overseas regulatory announcement detailing its Form 8-K filing with the U.S. Securities and Exchange Commission. This filing is significant for investors tracking BeiGene’s activities on global stock exchanges, as it outlines the company’s current financial and operational status. Investors should note that BeiGene’s American Depositary Shares are traded on NASDAQ, while its ordinary shares trade on the Hong Kong Stock Exchange.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.